Agtech Shareholder Update
Agtech Global International Inc. (OTC Pink: AGGL), a technology-driven CBD manufacturer, announced recent developments aimed at enhancing shareholder value and driving exponential revenue growth. The company is focusing on innovation through new product lines, including proprietary GENUS™ CBD products and a blockchain-enabled Virtual Retail Marketing System™. Notably, Agtech is pursuing a 10% equity stake in KRTL Biotech Inc., which specializes in psilocybin research. Plans for non-dilutive financing to support aggressive marketing initiatives were also revealed.
- Acquisition of a 10% non-dilutable equity stake in KRTL Biotech Inc.
- Introduction of new GENUS™ branded CBD products.
- Development of a blockchain-encrypted seed-to-sale platform for scalability.
- Implementation of a crypto rewards program aimed at a large customer base.
- None.
Newport Beach, California, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Agtech Global International Inc., (OTC Pink: AGGL) is a vertically integrated, technology powered CBD manufacturing and online marketing company offering its own range of GENUS™ CBD products through its advanced Virtual Retail Marketing System™, enabled by next generation BlockChain technology. (Name change to Galexxy Corporation pending)
“I am thrilled to provide an update on our significant progress towards our Q1- 2022 and to address the following question” says CEO, Ross Lyndon-James.
In such a competitive market, how will Agtech become successful and achieve increased shareholder value through exponential revenue growth going into 2022 for shareholders?
“We expect to succeed through Bold Innovation, Differentiation and Creative Marketing”
Through our recent corporate reorganization, Agtech is now a multi-faceted company offering science-based products and the latest patented, blockchain technologies to attract and serve a very large customer base. We are offering superior quality products coupled to an outstanding crypto customer rewards program.
In the last few months, we have acquired and are developing:
- A Unique New Techno-Health Play for Market Domination
- Inhouse product development and manufacturing capacity
- New GENUS™ branded CBD based proprietary and blended products
- Patented VRMS™ platform for installation in over 250,000 retail outlets
- Free “Business in a Box” marketing App aimed at 2 million Genus brand advocates
- Blockchain encrypted seed-to-sale operating platform for rapid and secure scaling
- Blockchain JV for future digital currency trading
- Blockchain solutions platform for Cannabis and Hemp businesses
Our latest development is a Memorandum of Understanding to acquire a
Ross Lyndon-James stated that “Investors who got into the cannabis industry early are now looking to medicinal psychedelics as the next big untapped market”. According to Brightfield Group, “It is worth noting that by mid-2021 there were dozens of publicly traded pharmaceutical companies in development phases on psilocybin or psychedelic based products”.
In conclusion, Agtech is pleased to announce that an arrangement is being organized to include non-dilutive financing to fund Agtech’s aggressive marketing plan for accelerated growth.
For further information:
Agtech Global International Inc.
Ross Lyndon-James
E: ross@galexxy.com
M: (949) 456 3972
Forward-Looking Information
This press release contains “forward-looking information” and “forward-looking statements” (collectively, “statements”). All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this press release.
https://twitter.com/AgtechGlobal
Attachment
FAQ
What is Agtech Global International Inc. (AGGL) focusing on for growth in 2022?
What recent acquisition has Agtech Global announced?
What are GENUS™ products by Agtech Global?
How is Agtech Global utilizing blockchain technology?
What marketing strategy will Agtech Global implement for growth?
